PCI The Journeys Within
CPHI 2026 – 23/07/2026
Media Pack
News

Current Edition

JCS - Volume 18 Issue 3 - Autumn 2026
Frankfurt 2027 – 12/10/26
ramusmedical
Regional News

CANCER RESEARCH UK AND NOVALGEN DOSE THE FIRST PATIENT IN THE PHASE 1 TRIAL OF T-CELL ENGAGER NVG-222

Cancer Research UK's Centre for Drug Development (CDD) and NovalGen today announce that the first patient has been dosed in a Phase 1 clinical trial evaluating NVG‑2...
16 March 2026 Regional News | Uncategorised
Continue Reading →
Regional News

START Appoints Dr. Frank Smith President of its XenoSTART Preclinical Research Business Unit

Dr. Smith will strengthen XenoSTART’s position as a premier drug development partner, translating PDX-driven insights into faster, more confident oncology developmen...
9 March 2026 Regional News
Continue Reading →
Regional News

Wisdom Bioscience Establishes Scientific Advisory Board to Advance Oral Cancer Diagnostics and Screening

Wisdom Bioscience, Inc., a biotechnology company pioneering non-invasive oral cancer diagnostics, today announced the formation of its Scientific Advisory Board (SAB...
9 March 2026 Regional News
Continue Reading →
Regional News

Expert Perspectives on Metabolic Drug Development

Interest in the development of new therapies to treat endocrine and metabolic diseases has skyrocketed, driven in part by increased commercial success and medical ef...
9 March 2026 Regional News
Continue Reading →
Regional News

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukaemia (CML) Therapy asciminib

Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced its Simcyp® Simulator enabled physiologically-based pharmacokinetic...
9 March 2026 Regional News
Continue Reading →
Regional News

Upperton Submits MHRA Licence Application for Annex 1 Sterile Manufacturing Facility Following APS Validation

Upperton has submitted its application to the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the approval of its new 7,000 sq. ft sterile manufact...
9 March 2026 Regional News
Continue Reading →
Regional News

Pumas 2.8 Sets a New Standard for Clinical Pharmacology and Pharmacometrics Technology with Embedded AI and Next Generation Estimation

PumasAI, a science-first organisation that turns data into life-saving decisions faster, today announced the release of Pumas version 2.8 to bring significant advanc...
26 February 2026 Regional News
Continue Reading →
Regional News

ClearNote Health’s Enhanced Avantect® Pancreatic Cancer Test Delivers Industry-Leading Early Detection Performance

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced the launch of its enhanced Avantect® Pancrea...
26 February 2026 Regional News
Continue Reading →
Regional News

Sygnature Discovery Unveils Strategic Rebrand to Cement Status as a Global Drug Discovery Partner

Sygnature Discovery, a leading drug discovery contract research organisation (CRO), has today announced a strategic brand relaunch, including a new website, cementin...
26 February 2026 Regional News
Continue Reading →
Regional News

Amorphical to Present Long-Term Phase 2 Crohn’s Disease Data at the 21st Congress of ECCO

Amorphical, a developer of nano-amorphous mineral-based pharmacologic agents, today announced that long-term data from its Phase 2 trial in moderate-to-severe Crohn’...
26 February 2026 Regional News
Continue Reading →
Quotient
CPHI 2026 – 20/07/2026
jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte